Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -6.84931506849 | 0.73 | 0.77 | 0.66 | 99238 | 0.72382551 | CS |
| 4 | -0.41 | -37.6146788991 | 1.09 | 1.15 | 0.66 | 903819 | 0.98990236 | CS |
| 12 | -0.62 | -47.6923076923 | 1.3 | 1.33 | 0.66 | 394675 | 1.02398616 | CS |
| 26 | -1.36 | -66.6666666667 | 2.04 | 2.12 | 0.66 | 296121 | 1.25439232 | CS |
| 52 | -11.52 | -94.4262295082 | 12.2 | 15.06 | 0.66 | 580793 | 4.38140781 | CS |
| 156 | -141.82 | -99.5228070175 | 142.5 | 225 | 0.66 | 449239 | 78.77469253 | CS |
| 260 | -4349.32 | -99.9843678161 | 4350 | 5032.5 | 0.66 | 1088863 | 361.79590839 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
